G01N 2333/07
Vaccinia virus
Official title: Vaccinia virus; Variola virus
G01N2333/07 (Vaccinia virus) appears on 18 US grants and 34 published applications in this corpus.
Search patents in G01N- Granted patents
- 18
- Published applications
- 34
- Assignees
- 25
- Inventors
- 54
- Latest grant
- 18 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 2 |
| 2005 | 1 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 3 |
| 2014 | 1 | 4 |
| 2015 | 1 | 1 |
| 2016 | 2 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 4 |
| 2020 | 4 | 3 |
| 2021 | 1 | 0 |
| 2022 | 0 | 2 |
| 2023 | 1 | 0 |
| 2024 | 0 | 2 |
By publication year.
Recent patents
- Nano-dynamic biosensor and fabrication method therefor18 Jul 2023US 11,703,505 B2Korea Research Institute of Standards and Science
- Schwann cell differentiation promoting agent and a peripheral nerve regeneration promoting agent28 Dec 2021US 11,207,354 B2Nippon Zoki Pharmaceutical Co., Ltd.
- Integral membrane protein display on poxvirus extracellular enveloped virions22 Dec 2020US 10,870,707 B2Vaccinex, Inc.
- Method for promoting the synthesis of collagen and proteoglycan in chondrocytes14 Jul 2020US 10,711,292 B2Nikkon Zoki Pharmaceutical Co., Ltd.
- Integral membrane protein display on poxvirus extracellular enveloped virions3 Mar 2020US 10,577,427 B2Vaccinex, Inc.
- Orthopoxvirus serology assays28 Mar 2024US 2024/0103002 A1
- Lipocalin-type prostaglandin d2 synthase production promoting agent4 Jan 2024US 2024/0000853 A1Hyogo College of Medicine
- Immune Assay for Monitoring Response to Oncolytic Vaccinia Virus and Uses Thereof1 Dec 2022US 2022/0381769 A1Regeneron Pharmaceuticals, Inc.
- Agent for promoting expression of n-acetylgalactosaminyltransferase containing extract from inflamed tissues inoculated with vaccinia virus17 Mar 2022US 2022/0079995 A1Nippon Zoki Pharmaceutical Co., Ltd.
- Lipocalin-type prostaglandin d2 synthase production promoting agent29 Oct 2020US 2020/0338135 A1Hyogo College of Medicine
Most cited
By later US patents
- Method for the rapid diagnosis of targets in human body fluids27US 7,723,124 B2Rapid Pathogen Screening, Inc. · 2010
- Device and method of use for detection and characterization of pathogens and biological materials13US 6,897,015 B2BioForce Nanosciences, Inc. · 2005
- Method for the rapid diagnosis of targets in human body fluids using undiluted samples11US 8,647,890 B2Rapid Pathogen Screening, Inc. · 2014
- Compositions and methods for modulating variola virus5US 6,783,759 B2The Trustees of the University of Pennsylvania · 2004
- Monoclonal antibodies against orthopoxviruses2US 7,914,788 B2The United States of America as represented by the Department of Health and Human Services · 2011